Schedule 13D ownership disclosure
Orexigen Theraptcs
Security class unavailable · CUSIP: 686164302
Event date: 2016-07-08
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 37.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001140361-16-072326
- Form type
- SC 13D
- Filer
- BAUPOST GROUP LLC/MA
- CIK
- CIK 1061768
- Filed
- Jul 12, 2016
- Reporting period
- Jul 08, 2016
- Description
- Schedule 13D beneficial ownership